Aurinia Pharmaceuticals Inc (AUPH)
EBITDA Growth
117.60%
TTM · Period ending:
AUPH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported117.60%period ending
Latest reported117.60%period ending
AUPH TTM EBITDA YoY % (-521.93% → 117.60%)
Year-over-year change
High-resolution chart · PNG
AUPH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -521.9289% |